Dallas, Texas From the Departments of Plastic Surgery and Ophthalmology, University of Texas Southwestern Medical Center.
Plast Reconstr Surg. 2012 Jan;129(1):149-157. doi: 10.1097/PRS.0b013e318230a1c7.
The most common form of blepharoptosis is involutional ptosis, commonly caused by the effect of progressive age on the levator aponeurosis. The treatment for this acquired ptosis is strictly surgical. For the plastic surgeon, the ideal lid ptosis repair provides the longest efficacy, the fewest complications and revisions, and, ultimately, the highest functional and cosmetic outcome for the patient. With over 100 different described techniques, there exists a need to make a comparison. A systematic review is considered a higher level of evidence because it is a review designed to be reproducible, with predetermined inclusion and exclusion criteria. To date, there has been no systematic review to study the efficacy and complication rates between different involutional lid ptosis repair techniques.
A systematic search of the English literature published in the PubMed and Cochrane Central Register of Controlled Trials databases yielded trials on comparison of different adult upper lid involutional ptosis repair techniques regarding their efficacy and complication rates. Predetermined inclusion and exclusion criteria were used.
: This systematic review revealed that there are no randomized, prospective, controlled comparison studies on involutional lid ptosis repair techniques.
Although this systematic review revealed a lack of level I data in comparing the different ptosis repair techniques, it is important that the existing studies be reviewed and pooled to improve patient outcomes and to provide direction for future research. In the absence of higher level data studies, the authors propose a treatment algorithm for involutional ptosis repair.
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
最常见的眼睑下垂形式是退行性眼睑下垂,通常由年龄增长对提上睑肌腱膜的影响引起。这种获得性上睑下垂的治疗方法严格是手术治疗。对于整形医生来说,理想的眼睑下垂修复术应提供最长的疗效、最少的并发症和修订、最终为患者带来最高的功能和美容效果。已有超过 100 种不同的描述性技术,因此需要进行比较。系统评价被认为是一种更高水平的证据,因为它是一种旨在具有可重复性的评价,具有预先确定的纳入和排除标准。迄今为止,尚无系统评价研究不同退行性眼睑下垂修复技术的疗效和并发症发生率。
对 PubMed 和 Cochrane 中央对照试验登记数据库中发表的英文文献进行系统检索,以研究比较不同成人上眼睑退行性下垂修复技术的疗效和并发症发生率的试验。使用了预先确定的纳入和排除标准。
本系统评价显示,没有关于退行性眼睑下垂修复技术的随机、前瞻性、对照比较研究。
尽管本系统评价显示在比较不同的上睑下垂修复技术方面缺乏一级数据,但重要的是要对现有研究进行审查和汇总,以改善患者的结果,并为未来的研究提供指导。在缺乏更高水平数据研究的情况下,作者提出退行性眼睑下垂修复的治疗算法。
临床问题/证据水平:治疗,IV。